The Living Guidelines: UA/NSTEMI Recommendations for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy Polling Results for CLASS IIb Guidelines

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Class IIb Guidelines
1- For UA/NSTEMI patients in whom PCI is selected as a post angiography management strategy, it may be reasonable to omit an i.v. GP IIb/IIIa inhibitor if not started before diagnostic angiography for troponin negative patients without other clinical or angiographic high risk features. (Class IIb Level of Evidence: C)

 UA/NSTEMI Guidelines Class IIb Recommendation 1 for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy should be: CLASS I CLASS IIa CLASS IIb CLASS III